Lipid News

A versatile lipid second messenger

Hui Liu Alex Toker
By Hui Liu and Alex Toker
April 01, 2019

The phosphoinositide 3-kinase, or PI3K, signaling pathway has been studied intensively since its discovery in the mid-1980s and has been found to play a critical role in the regulation of normal cellular physiology. The pathway is dysregulated in pathophysiologies such as cancer and diabetes.

Much of this work focused on the lipid product of PI3K activity, PIP3, or PI(3,4,5)P3, derived from the phosphorylation of the membrane phosphoinositide PI(4,5)P2. PIP3 is a true lipid-derived second messenger: It is absent in unstimulated cells, it is synthesized rapidly at sites of PI3K activation at the plasma membrane, it is removed by the action of the lipid phosphatase and tumor suppressor PTEN, and it initiates PI3K signal relay by recruiting effector proteins such as the serine/threonine protein kinase Akt and downstream nodes such as the mTOR pathway.

By contrast, a separate lipid product of PI3K, PI(3,4)P2, remained largely out of the limelight. Recent studies point to an important role for this neglected lipid second messenger, with some surprises. Unlike PIP3, PI(3,4)P2 can be generated by more than one route of synthesis. 5' phosphoinositide phosphatases can dephosphorylate PIP3 to generate PI(3,4)P2. Alternatively, class II PI3-kinases can use PI4P as a substrate to generate PI(3,4)P2. And PI(3,4)P2 can be degraded by lipid phosphatases such as PTEN and INPP4B — tumor suppressors frequently inactivated in human cancers.

Slide 1 In phosphoinositide metabolism, PIP3, labeled PI(3,4,5)P3, is generated by phosphorylation of the precursor PI(4,5)P2 by the action of class I PI3-kinases, and the reverse reaction is generated by the phosphatase PTEN. SHIP1/2 lipid phosphatases dephosphorylate PIP3 to generate PI(3,4)P2, which is degraded further by INPP4A/B to PI3P. Class II PI3-kinases also can generate PI(3,4)P2 by phosphorylating PI4P. Alex Toker

PI(3,4)P2–binding proteins, such as TAPP1/2 and lamellipodin, link PI3K/PI(3,4)P2 to cytoskeletal remodeling. However, many proteins with modular domains that directly bind to PIP3, including Akt, also bind to PI(3,4)P2. This has hampered identification of any potential unique signaling roles for PI(3,4)P2. Advanced high-resolution live cell imaging and microscopy show that PI(3,4)P2 is localized predominantly at early endosomes, although some plasma membrane localization is also evident. In growth factor signaling, this pool of PI(3,4)P2 seems to be generated predominantly by the action of phosphatases acting on PIP3. In contrast, PIP3 is localized exclusively at the plasma membrane, where class I PI3-kinases are activated.

These discrete intracellular pools of PI(3,4)P2 and PIP3 have remarkable consequences. In mammals, three Akt isoforms exist: Akt1, Akt2, and Akt3. Genetic ablation studies have shown that Akt isoforms play a non-redundant role both in normal development and in diseases such as cancer. Although a few isoform-specific substrates have been identified, of the 200-plus Akt substrate proteins identified, most are not unique to any one Akt. So how is specificity achieved? Recent research shows that Akt1 and Akt3 are activated specifically by the plasma membrane PIP3 pool, whereas Akt2 seems to be exclusively localized and activated by the endomembrane pool of PI(3,4)P2, at early endosomes and also early lysosomes. In the latter case, upon nutrient deprivation, class II PI3-kinases produce PI(3,4)P2 at the lysosome, leading to suppressed mTORC1 activity. Class II PI3-kinases also been have implicated in the formation of clathrin-mediated endocytic cups leading to vesicle fission, a process shown to be mediated by PI34P2.

A picture begins to emerge: Discrete pools of PIP3 and PI(3,4)P2 selectively activate Akt isoforms leading to presumably unique substrate phosphorylation patterns and downstream effects, although this has yet to be demonstrated rigorously. These observations begin to ascribe a critical role for PI(3,4)P2 in cell biology and also explain the roles of Akt isoforms in phenotypes associated with disease.

Questions remain about the intracellular localization of PI3K lipid second messengers and their effectors. The answers will come from continued advances in imaging technologies using live cells and tissues, giving a more complete picture of how specificity is achieved in this versatile lipid signaling pathway.

Hui Liu
Hui Liu

Hui Liu is an instructor in pathology and a researcher in the Toker lab at Beth Israel Deaconess Medical Center.

Alex Toker

Alex Toker is a professor in the department of pathology and chief of the division of signal transduction in the departments of medicine and pathology and the cancer center at Beth Israel Deaconess Medical Center, Harvard Medical School, and a Journal of Biological Chemistry associate editor.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A small army of researchers races to build a coronavirus interactome
News

A small army of researchers races to build a coronavirus interactome

April 01, 2020

Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.

Parkinson's  Awareness Month
Health Observance

Parkinson's Awareness Month

April 01, 2020

It is the second-most common progressive neurodegenerative disease, occurring in 1% of people over the age of 60 and in 5% of people over 85.

Multiomics meets antimalarials
Journal News

Multiomics meets antimalarials

March 31, 2020

Researchers in Australia use an innovative multiomics approach to analyze a new drug against malaria parasites.

From the journals: JLR
Journal News

From the journals: JLR

March 31, 2020

Topics include the role of HDL and Smo in inhibiting beta-cell apoptosis, lipid asymmetry in a plasma membrane and apolipoproteins and dementia risk.

Researchers retool genomics labs to provide COVID-19 testing
News

Researchers retool genomics labs to provide COVID-19 testing

March 30, 2020

The pipetting robots are already in place, but that doesn’t make it easy. Here's how academic laboratories are quickly pivoting to provide testing for the coronavirus.

Research on a budget
Essay

Research on a budget

March 30, 2020

As a professor at a small university, Peter Lyons has developed ways of reaching his research goals with limited funding, and he shares some of them here.